Nocturnal Blood Pressure Non-Dipping as an Autonomic Biomarker of Psychosis and Movement Disorder Severity in Pediatric Epilepsy
Objective: To investigate the association between 24-hour ambulatory blood pressure monitoring (ABPM) patterns, particularly nocturnal non-dipping, and psychosis severity, movement disorder burden, and non-motor symptoms…Incidence and movement disorders associated with Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT) in the Princess Maha Chakri Sirindhorn Medical Center (MSMC)
Objective: To identify incidence and clinical features of SREAT patients in MSMC. Background: SREAT patients could present with encephalopathy with various neurological abnormalities, including behavioral…Iron-independent initiation of neurodegeneration in BPAN
Objective: Beta-propeller protein–associated neurodegeneration (BPAN) is caused by mutations in WDR45 and classified within the neurodegeneration with brain iron accumulation (NBIA) spectrum. Although brain iron…Exploratory Results From a Phase 1 Study of NIO752 in Progressive Supranuclear Palsy Supporting Further Clinical Studies
Objective: To report exploratory analyses of biomarker and clinical outcomes from a first-in-human study of NIO752 in progressive supranuclear palsy (PSP) and provide rationale for…Perioperative and Longitudinal Outcomes Following Deep Brain Stimulation in Patients with Movement Disorders: A Retrospective Review From a Movement Disorder Program
Objective: To evaluate postoperative symptoms improvement and quality-of-life outcomes in patients with movement disorders following deep brain stimulation (DBS). Background: Deep brain stimulation is an…Redefining Anatomical Boundaries, An Atypical Case of MV-PLUS with Supratentorial extension.
Objective: To report the first case of Multinodular and Vacuolating Posterior Fossa Lesions of Unknown Significance (MV-PLUS) with atypical supratentorial temporal extension, expanding the known…Molecular Profiling of Brain-Derived Extracellular Vesicles and Fluid Biomarkers in Parkinsonism: Distinct Signatures and Clinical Correlates in Progressive Supranuclear Palsy
Objective: (1) To validate serum-based enrichment of neuronal (L1CAM+) and microglial (TMEM119+) EVs in PSP; (2) to characterize α-synuclein, tau, and inflammatory/autophagic mediators in EVs…Does Fgatir Hypointensity Predict Outcomes After Deep Brain Stimulation For Action Tremors
Objective: To test whether efficacy of Deep Brain Stimulation (DBS) in different action tremor syndromes (Essential tremor, ET, ET-plus, or dystonic tremor as per IPMDS…Levels of cytokines in the cerebrospinal fluid of patients depending on the stages of Parkinson’s disease
Objective: To study of cytokine levels in serum and cerebrospinal fluid of patients with different stages of PD. Background: The clinical course of Parkinson's disease…Safety and Effectiveness of DaxibotulinumtoxinA in Cervical Dystonia: A Systematic Review and Meta-Analysis of Different Doses
Objective: To evaluate the effectiveness and safety of DaxibotulinumtoxinA (DAXI) in patients diagnosed with cervical dystonia (CD). Background: Botulinum toxins (BoNTs) are the first-line therapy…
- « Previous Page
- 1
- …
- 189
- 190
- 191
- 192
- 193
- …
- 1942
- Next Page »